Finance

Beta
Lists
TRAX:NASDAQ
First Tracks Biotherapeutics Inc
$38.53
+4.50%
(+1.66) 1D
Jul 21, 2:11:21 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRAX...
Open
$37.53
High
$42.90
Low
$37.51
Mkt. cap
1.34B
Avg. vol.
859.39K
Volume
744.85K
52-wk high
$42.90
52-wk low
$14.88
Shares outstanding
34.89M
No. of employees
104
Open
$37.53
High
$42.90
Low
$37.51
Mkt. cap
1.34B
Avg. vol.
859.39K
Volume
744.85K
52-wk high
$42.90
52-wk low
$14.88
Shares outstanding
34.89M
No. of employees
104
News stories
From sources across the web
About First Tracks Biotherapeutics Inc
CEO-
Employees104
Founded2019
Headquarters-
SectorBiotechnology
Websitefirsttracksbio.com
Analyst ratings
Based on 8 analysts giving stock ratings to TRAX in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for TRAX in the last 3 months.
Highest
Current $38.53
$54.00 (+40.15%)
Average
$40.88 (+6.10%)
Lowest
$30.00 (-22.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Buy
Reiterated
$48.00
+24.6%
07/21/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$54.00
+40.2%
07/20/2026
Unknown Analyst
UBS
Buy
Maintained
$45.00
+16.8%
07/10/2026
Anupam Rama
J.P. Morgan
Buy
Reiterated
$30.00
-22.1%
07/09/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$30.00
-22.1%
07/10/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$44.00
+14.2%
07/10/2026
Martin Fan
Wedbush
Buy
Maintained
$30.00
-22.1%
05/15/2026
David Risinger
Leerink Partners
Buy
Initiated
$46.00
+19.4%
04/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
41.46M
33.96M
Total research and development expenses
-
-
Selling, general, and admin expenses
9.82M
18.86M
Operating expense
51.28M
52.81M
Total operating expenses
51.28M
52.81M
Operating income
-51.28M
-52.81M
Other non operating income
-7.00K
-1.00K
EBT including unusual items
-47.20M
-50.48M
EBT excluding unusual items
-47.20M
-50.48M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-47.20M
-50.48M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
4.09M
2.33M
Interest expense
-
-
Net interest expenses
4.09M
2.33M
Depreciation and amortization charges
-
-
EBITDA
-51.13M
-52.69M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer